These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30789840)

  • 21. Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Decade of Experience.
    Spruit JR; de Vries TAC; Hemels MEW; Pisters R; de Groot JR; Jansen RWMM
    Drugs Aging; 2024 Sep; 41(9):725-740. PubMed ID: 39141209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis.
    Wang TF; Carrier M; Fournier K; Siegal DM; Le Gal G; Delluc A
    Thromb Haemost; 2022 May; 122(5):830-841. PubMed ID: 34399433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of direct acting oral anticoagulants and vitamin K antagonists in nonvalvular atrial fibrillation - a network meta-analysis of real-world data.
    Hirschl M; Kundi M
    Vasa; 2019 Mar; 48(2):134-147. PubMed ID: 30376416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of New Oral Anticoagulants for Patients with Chronic Kidney Disease.
    Zbigniew K; Hubert S; Andrzej J; Michal S
    Curr Pharm Des; 2018; 24(38):4505-4510. PubMed ID: 30706805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation and chronic kidney disease: A review of options for therapeutic anticoagulation to reduce thromboembolism risk.
    Bhatia HS; Hsu JC; Kim RJ
    Clin Cardiol; 2018 Oct; 41(10):1395-1402. PubMed ID: 30259531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort.
    Sy J; Hsiung JT; Edgett D; Kalantar-Zadeh K; Streja E; Lau WL
    Am J Nephrol; 2021; 52(3):199-208. PubMed ID: 33789276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOACs use in extreme body-weighted patients: results from the prospective START-register.
    Guarascio M; Bertù L; Donadini MP; Antonucci E; Palareti G; Ageno W
    Intern Emerg Med; 2023 Sep; 18(6):1681-1687. PubMed ID: 37301770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic hemodialysis: a meta-analysis of randomized controlled trials.
    Navalha DDP; Felix N; Nogueira A; Clemente M; Marinho AD; Ferreira ROM; Pasqualotto E; Dagostin CS; Pinto LCS; Fernandes GC
    Int Urol Nephrol; 2024 Jun; 56(6):2001-2010. PubMed ID: 38153665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct Oral Anticoagulant Use in Chronic Kidney Disease and Dialysis Patients With Venous Thromboembolism: A Systematic Review of Thrombosis and Bleeding Outcomes.
    Cheung CYS; Parikh J; Farrell A; Lefebvre M; Summa-Sorgini C; Battistella M
    Ann Pharmacother; 2021 Jun; 55(6):711-722. PubMed ID: 33073581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct oral anticoagulants in chronic kidney disease: an update.
    Mavrakanas TA; Charytan DM; Winkelmayer WC
    Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):489-496. PubMed ID: 32740218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation.
    Dhaese SAM; De Vriese AS
    Mayo Clin Proc; 2023 May; 98(5):750-770. PubMed ID: 37028979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unresolved issues in the use of direct acting oral anticoagulants.
    Chan N; Hirsh J
    Expert Rev Cardiovasc Ther; 2023; 21(12):913-921. PubMed ID: 37837206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review.
    Briere JB; Bowrin K; Coleman C; Fauchier L; Levy P; Folkerts K; Toumi M; Taieb V; Millier A; Wu O
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):27-36. PubMed ID: 30169975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism.
    Zeng J; Zhang X; Lip GYH; Shu X; Thabane L; Tian J; Li G
    Clin Appl Thromb Hemost; 2019; 25():1076029619853629. PubMed ID: 31132874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DOAC use in patients with chronic kidney disease.
    Kcükköylü S; Rump LC
    Hamostaseologie; 2017; 37(4):286-294. PubMed ID: 29582930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
    Feldberg J; Patel P; Farrell A; Sivarajahkumar S; Cameron K; Ma J; Battistella M
    Nephrol Dial Transplant; 2019 Feb; 34(2):265-277. PubMed ID: 29509922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.